Market Research Reports

Hyaluronic Acid Products Market (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

106pages
Published Date: 2014-04-30
 

Description


About this report

This report titled ‘Hyaluronic Acid Products Market (Single-Injection, Three-Injection Cycle and Five-Injection Cycle) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019’ exhaustively elucidates current as well as anticipated position of hyaluronic acid – an essential glycosaminoglycan that is essential to the transportation of nutrients in the body. 

The report comprises a detailed market overview section giving an insight into products that exist within this market. It then goes on to discuss the detailed dynamics of this market with a special focus on growth drivers and inhibitors as well as opportunities. A market attractiveness analysis (based on geographical markets) and Porter’s five forces analysis for products that come under the purview of the global hyaluronic market are other highlights of this section. Market shares occupied by leading players in this arena as of 2012 are also provided. A list of recommendations to help new and existing players strengthen their industry standing forms yet another vital feature of this report. The final part of the report is comprised of a detailed company profiles section complete with leading players’ product portfolio, financial status, growth strategies, SWOT analysis and recent developments. Market players such as Sanofi (Genzyme), Merz Aesthetics, Anika Therapeutics, Allegran Inc, and Seikagaku have been featured in the Company Profiles section. 

Market Overview

Hyaluronic acid (HA) can be classified as a glycosaminoglycan that helps transport nutrients within the body while aiding water retention in the tissue. It occurs naturally in the body in parts such as the eye cavity, immune system, and joints. HA has also been observed to be vital to the articular cartilage where it occurs in the form of a coat around each chondrocyte. For the purpose of this report, the global market for hyaluronic acid has been segmented on the basis of applications, products, and key geographic markets.

The market for products is further divided as: single-injection, three-injection cycle and five-injection cycle. The applications market, on the other hand, is segmented as dermal fillers, ophthalmic surgery, osteoarthritis, and vesicoureteral reflux (VUR). From the geographical standpoint, this market is subdivided into four key regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). 

Market forecasts and sizes for 2011 to 2019 are provided in terms of revenue (USD million) with 2012 being the base year. This data has been provided for each application type, technology type, and geographical markets complete with any sub-segments that may exist. This market report also states the compounded annual growth rate (CAGR) of the hyaluronic acid products market over the 2013 -2019 forecast period for each of the segments mentioned earlier. 

Based on products, the global hyaluronic acid market is segmented as follows:

Hyaluronic Acid Products Market, by Products
  • Single-injection
  • Three-injection cycle
  • Five-injection cycle
Hyaluronic Acid Products Market, by Applications
  • Osteoarthritis
  • Ophthalmic
  • Dermal Fillers
  • Vesicoureteral Reflux (VUR)
Hyaluronic Acid Products Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
This report gives you access to decisive data such as:
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 
Key highlights of this report
  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements in the micro servers industry
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments

Table of Contents


Table of Content

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
      1.3.2 Assumptions and Stipulations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Hyaluronic Acid Products Market (2013 & 2019)
      2.1.1 Global Hyaluronic Acid Products Market, by Products, 2012 (USD Million)
2.2 Comparative Analysis: Global Hyaluronic Acid Products Market, By Geography, 2012 and 2019 (Value %)

Chapter 3 Market Overview
3.1 Introduction and Market Definition
3.2 Market Dynamics
      3.2.1 Drivers
      3.2.2 Restraints
      3.2.3 Market Opportunities
3.3 Porter’s Five Forces Analysis: Global Hyaluronic Acid Products Market
      3.3.1 Bargaining power of suppliers
      3.3.2 Bargaining power of buyers
      3.3.3 Threat of Substitutes
      3.3.4 Threat of New Entrants
      3.3.5 Competitive Rivalry
3.4 Market Attractiveness Analysis
      3.4.1 Market Attractiveness Analysis: Global Hyaluronic Acid Products Market
3.5 Global Market Share Analysis for the Hyaluronic Acid Products, by Key Players, 2012 (Value %)
      3.5.1 Global Market Share by Key Players, 2012 (Value %)

Chapter 4 Global Hyaluronic Acid Products Market, by Products
4.1 Overview
      4.1.1 Global Hyaluronic Acid Products Market Revenue, by Products, 2011 – 2019 (USD Million)
4.2 Single-Injection Cycle Products
      4.2.1 Global Single-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
4.3 Three-Injection Cycle Products
      4.3.1 Global Three-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
4.4 Five-Injection Cycle Products
      4.4.1 Global Five-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)

Chapter 5 Global Hyaluronic Acid Products Market, by Applications
5.1 Overview
      5.1.1 Global Hyaluronic Acid Products Market Revenue, by Applications, 2011 – 2019 (USD Million)
5.2 Osteoarthritis
      5.2.1 Global Hyaluronic Acid Products Market Revenue, by Osteoarthritis Application, 2011 – 2019 (USD Million)
5.3 Ophthalmic
      5.3.1 Global Hyaluronic Acid Products Market Revenue, by Ophthalmic Application, 2011 – 2019 (USD Million)
5.4 Dermal Fillers
      5.4.1 Global Hyaluronic Acid Products Market Revenue, by Dermal Filler Application, 2011 – 2019 (USD Million)
5.5 Vesicoureteral Reflux (VUR)
      5.5.1 Global Hyaluronic Acid Products Market Revenue, by Vesicoureteral Reflux Application, 2011 – 2019 (USD Million)

Chapter 6 Global Hyaluronic Acid Products Market, by Geography
6.1 Overview
      6.1.1 Global Hyaluronic Acid Products Market Revenue, by Geography, 2011 – 2019 (USD Million)
6.2 North America
      6.2.1 North America Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
      6.3.1 Europe Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 RoW Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Recommendations
7.1 Market Strategy for Success
      7.1.1 Focus on improving technology in order to increase the accuracy and reduce side-effects
      7.1.2 Multinational companies established partnership with the local professional/organization to expand their business
7.2 Barriers to be considered
      7.2.1 High cost is a barrier for sufficient market expansion

Chapter 8 Company Profiles
8.1 Alcon, Inc.
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Allergan, Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 Anika Therapeutics, Inc.
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 F. Hoffmann-La Roche Ltd.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 Ferring Pharmaceuticals, Inc.
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 Fidia Farmaceutici SpA
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product portfolio
      8.6.4 Business Strategies
      8.6.5 Recent developments
8.7 GALDERMA S.A.
      8.7.1 Company Profile
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 Hyaltech Ltd.
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 LifeCore Biomedical LLC,
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments
8.10 Meiji Seika Pharma Co., Ltd.
      8.10.1 Company Profile
      8.10.2 Financial Overview
      8.10.3 Product Portfolio
      8.10.4 Business Strategies
      8.10.5 Recent Developments
8.11 Merz Aesthetics, Inc.
      8.11.1 Company Overview
      8.11.2 Financial Overview
      8.11.3 Product Portfolio
      8.11.4 Business Strategies
      8.11.5 Recent Developments
8.12 Sanofi
      8.12.1 Company Overview
      8.12.2 Financial Overview
      8.12.3 Product Portfolio
      8.12.4 Business Strategies
      8.12.5 Recent Developments
8.13 Salix Pharmaceuticals, Inc.
      8.13.1 Company Overview
      8.13.2 Financial Overview
      8.13.3 Product Portfolio
      8.13.4 Business Strategies
      8.13.5 Recent Developments
8.14 Seikagaku Corporation
      8.14.1 Company Overview
      8.14.2 Financial Overview
      8.14.3 Product Portfolio
      8.14.4 Business Strategies
      8.14.5 Recent Developments
8.15 Shanghai Jingfeng Pharmaceutical Co., Ltd.
      8.15.1 Company Overview
      8.15.2 Financial Overview
      8.15.3 Product Portfolio
      8.15.4 Business Strategies
      8.15.5 Recent Developments
8.16 Smith & Nephew plc
      8.16.1 Company Overview
      8.16.2 Financial Overview
      8.16.3 Product Portfolio
      8.16.4 Business Strategies
      8.16.5 Recent Development
8.17 TRB CHEMEDICA INTERNATIONAL SA
      8.17.1 Company Overview
      8.17.2 Financial Overview
      8.17.3 Product Portfolio
      8.17.4 Business Strategies
      8.17.5 Recent Developments
8.18 Zimmer Holdings, Inc.
      8.18.1 Business Overview
      8.18.2 Financial Overview
      8.18.3 Product Portfolio
      8.18.4 Business Strategies
      8.18.5 Recent Developments

List of Figures

FIG. 1 Hyaluronic Acid Products: Market Segmentation
FIG. 2 Global Hyaluronic Acid Products Market, by Products, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Hyaluronic Acid Products Market, by Geography, 2012 and 2019 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Hyaluronic Acid Products Market
FIG. 5 Production Methods of Hyaluronic acid
FIG. 6 Market Attractiveness Analysis: Global Hyaluronic Acid Products Market
FIG. 7 Market Share Analysis: Hyaluronic Acid Products Market, 2012 (Value %)
FIG. 8 Comparative Analysis: Types of Hyaluronic Acid Products
FIG. 9 Global Single-Injection Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Three-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Five-Injection Cycle Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Hyaluronic Acid Products Market Revenue, by Osteoarthritis Application, 2011 – 2019 (USD Million)
FIG. 13 Global Hyaluronic Acid Products Market Revenue, by Ophthalmic Application, 2011 – 2019 (USD Million)
FIG. 14 Global Hyaluronic Acid Products Market Revenue, by Dermal Filler Application, 2011 – 2019 (USD Million)
FIG. 15 Global Hyaluronic Acid Products Market Revenue, by Vesicoureteral Reflux Application, 2011 – 2019 (USD Million)
FIG. 16 North America Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Europe Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Asia-Pacific Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 RoW Hyaluronic Acid Products Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Alcon, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Allergan, Inc., Annual Sales Revenue: 2010 – 2012 (USD Million)
FIG. 22 Anika Therapeutics, Inc., Annual Revenue: 2010– 2012 (USD Million)
FIG. 23 F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 Galderma S.A., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 25 Lifecore Biomedical LLC., Annual Revenue: 2010– 2012 (USD Million)
FIG. 26 Meiji Seika Pharma Co., Ltd., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Merz Aesthetics Inc., Annual revenue: 2010 – 2012 (USD Million)
FIG. 28 Sanofi, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Salix Pharmaceuticals, Inc., Annual Revenue: 2010 - 2012 (USD Million)
FIG. 30 Seikagaku Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 31 Smith & Nephew PLC, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 32 Zimmer Holdings. Inc., Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Hyaluronic Acid Products Market (2013 & 2019)
TABLE 2 Global Hyaluronic Acid Products Market Revenue, by Products, 2011 –2019 (USD Million)
TABLE 3 Global Hyaluronic Acid Products Market Revenue, by Applications, 2011 –2019 (USD Million)
TABLE 4 Global Hyaluronic Acid Products Market Revenue, by Geography, 2011 –2019 (USD Million)

Enquiry Before Buying


Free Market Analysis


Hyaluronic acid (HA) is a unique non-sulfated glycosaminoglycan, distributed throughout the body in connective tissues, epithelial and neural tissues. Hyaluronic acid contributes significantly to cell proliferation and migration and is observed to be an integral component of the extracellular matrix. Hyaluronic acid has wide number of applications such as orthopedic surgery, rheumatology, ophthalmology, otolaryngology, dermatology and plastic surgery, wound healing and drug delivery. Hyaluronic acid products are segmented on the basis of treatment regimen into single-injection, three-injection cycle and five-injection cycle products. In addition, HA injectable can be utilized in a range of applications such as osteoarthritis, dermal fillers, ophthalmic surgery and vesicoureteral reflux (VUX).

The major factors driving this market are increasing geriatric population globally, high awareness about anti-aging procedures, patient’s preference for the treatment with minimum side-effects and rising demand for minimally invasive surgical procedures.

In products segment, five-injection cycle products is the largest marketsegment and single-injection market segment is growing with highest CAGR during forecast period from 2013 to 2019. Hyaluronic acid products market is observing a global shift in usage of five-injection cycle to single-injection cycle treatment as there has been a considerable change in preference of patients towards short duration treatment. This shift in preference is mainly related to convenience of patients as they try to avoid side-effects such as redness, inflammation and itching experienced after every treatment and five-injection cycle is a prolonged treatment compared to single-injection.

Dermal fillers is the largest market closely followed by osteoarthritis market and vesicoureteral reflux (VUR) applications market. VUR application market for hyaluronic acid products is growing at a highest CAGR during the forecast period from 2013 to 2019. The segment is mainly driven by aging population, high demand for minimally invasive surgical treatments and high awareness about beauty enhancements.

North America is the largest hyaluronic acid products market owing to high product demand, acceptance of premium priced products and high awareness about modern treatments. Europe is the second largest hyaluronic acid products market. It experienced an economic downturn that created turmoil in hyaluronic acid products marketas reimbursement policies turned out to be inconvenient and the premium priced products were accepted only in specific countries. Asia-Pacific and Rest of the World (RoW) were estimated to be the future hyaluronic acid products destinations as there is market driven by economic development, healthcare facility enhancements and high demand for minimally invasive surgeries.

Allergan, Inc., Anika Therapeutics, Inc. and Merz Aesthetics are major companies leading the hyaluronic acid products market. Major applications of hyaluronic acid products involves dermal filler and osteoarthritis treatment, hence, the major manufacturers have their product portfolio including hyaluronic acid injections applied in these two application areas.

global-hyaluronic-acid-products-market-by-segments-2012

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research